COVID-19: use of ACE inhibitors and angiotensin-receptor blockers

David Millar-Jones examines recent newspaper stories on the use of ACE inhibitors and angiotensin-receptor blockers in people with COVID-19, and their implications for primary care
David Millar-Jones examines recent newspaper stories on the use of ACE inhibitors and angiotensin-receptor blockers in people with COVID-19, and their implications for primary care